Open Access

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - CON.

Congress Session

About the speaker

Doctor Thomas Cuisset

AP-HM - Hospital La Timone, Marseille (France)
4 presentations
0 follower

5 more presentations in this session

Aspirin is out for primary prevention of cardiovascular disease - PRO.

Speaker: Professor J. Armitage (Oxford, GB)

Thumbnail

Aspirin is out for primary prevention of cardiovascular disease - CON.

Speaker: Professor C. Patrono (Rome, IT)

Thumbnail

Aspirin is out for primary prevention of cardiovascular disease - Discussion.

Thumbnail

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - PRO.

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Thumbnail

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - Discussion.

Thumbnail

Access the full session

Controversies in antithrombotic treatment for primary and secondary prevention

Speakers: Doctor T. Cuisset, Professor J. Armitage, Professor C. Patrono, Doctor J. Eikelboom
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

Open Access

How should I treat a patient with severe aortic stenosis and coronary artery disease at low surgical risk? – discussion

27 August 2021

Open Access

A 70-year-old patient with severe aortic stenosis and coronary artery disease at low surgical risk: how I did treat.

27 August 2021

Open Access

A 70-year-old patient with severe aortic stenosis and coronary artery disease at low surgical risk: how I would treat.

27 August 2021

This platform is supported by

logo Novo Nordisk